Moyamoya disease presenting with repeated ruptures of a lateral posterior choroidal artery aneurysm: illustrative case Authors: Rie Hashizume, Shoji Yasuda, Masaki Kumagai, Hirofumi Matsubara, Yusuke Egashira, Yukiko Enomoto, Tsuyoshi Izumo Published: 2026 ABSTRACT AbstractBACKGROUNDPeripheral aneurysms may develop along collateral pathways in patients with moyamoya disease (MMD); however, their optimal management remains unclear. The authors report a case of a lateral posterior choroidal artery aneurysm associated with MMD that ruptured three times within a short period, along with a review of the literature.OBSERVATIONSA 54-year-old woman with MMD, who had remained asymptomatic for 19 years, developed an intraventricular hemorrhage 1 month after periventricular aneurysm dilation was detected on annual imaging follow-up. Rebleeding occurred on days 7 and 10, and vertebral angiography revealed a 6-mm aneurysm in the distal segment of the left posterior choroidal artery. Transarterial embolization using liquid material achieved complete occlusion of the aneurysm; however, the patient developed right hemiparesis due to a left corona radiata infarction and was transferred to a rehabilitation hospital, with a modified Rankin Scale score of 5.LESSONSRebleeding from peripheral aneurysms associated with MMD is a predictor of poor prognosis, and spontaneous aneurysm regression during observational management or after bypass surgery requires several months. Accordingly, when such peripheral aneurysms are detected, early revascularization should be planned. However, in cases of rupture, prompt aneurysm-directed treatment, including endovascular or microsurgical intervention, is warranted to prevent clinical deterioration. https://thejns.org/doi/10.3171/CASE26167 Keywords: moyamoya disease, peripheral aneurysm, transarterial embolization, strokeABBREVIATIONS: IVH = intraventricular hemorrhage, LPChA = lateral posterior choroidal artery, MMD = moyamoya disease, mRS = modified Rankin Scale, NBCA = N-butyl-2-cyanoacrylate, VD = ventricular drainage The incidence of intracranial aneurysms associated with moyamoya disease (MMD) has been reported to range from 3.6% to 18%.1,2 Peripheral aneurysms may also develop along the collateral circulation. However, the optimal treatment strategy and timing for such peripheral aneurysms have not yet been established. Herein, we report a case of MMD in which a peripheral aneurysm developed during long-term follow-up, causing repeated intraventricular hemorrhages (IVHs) within a short period. Illustrative Case A 54-year-old woman with incidentally diagnosed MMD was followed up annually using MR angiography. During 19 years of follow-up period, no neurological symptoms or remarkable imaging changes were observed (Fig. 1A and B). During her annual imaging follow-up, newly developed periventricular aneurysm dilation was detected (Fig. 1C and D); however, we decided to continue observation as the size was too small. Subsequently, she developed sudden disturbances in consciousness and aphasia and was transferred to our hospital. CT revealed an IVH with acute hydrocephalus (Fig. 2A). Conservative treatment was initiated with blood pressure control because her consciousness impairment was mild (Glasgow Coma Scale score 15: eyes 4, verbal 5, and motor 6). The following morning, her consciousness deteriorated owing to hydrocephalus, and ventricular drainage (VD) was performed. Although the bleeding source was presumed to be an aneurysm of the left lateral posterior choroidal artery (LPChA), elective revascularization surgery was planned because the aneurysm was located along the collateral circulation and was expected to regress after bypass surgery. On day 7, her consciousness suddenly deteriorated again. CT revealed an increase in the IVH, indicating rebleeding from the left LPChA aneurysm (Fig. 2B). Endoscopic evacuations of the intraventricular hematoma and VD were performed. On day 10, the patient experienced a third rebleeding episode. Bloody CSF rapidly flowed out of the ventricular drain 1 hour after sedation was terminated. CT revealed hematoma expansion and a mass lesion in the left lateral ventricle, suggestive of aneurysm rerupture (Fig. 2C). Time-of-flight MR angiograms. A and B:Fifteen years previously. C and D:One month before the initial rupture. Newly developed aneurysm dilation is detected in the distal portion of the left LPChA (arrowhead). The maximum size is 2.5 mm. A: Day 0. CT scan showing an IVH in the left lateral ventricle with hydrocephalus. B: Day 7. CT scan showing an IVH in the lateral, third, and fourth ventricles. C:Day 11. CT scan showing hematoma expansion with a mass suggestive of a pseudoaneurysm in the left lateral ventricle (arrowhead). Given the high risk of further rebleeding, emergency digital subtraction angiography and transarterial embolization of the aneurysm were performed. Emergency digital subtraction angiography revealed a 6-mm aneurysm in the distal portion of the left LPChA (Fig. 3A–C), which was embolized using 33% N-butyl-2-cyanoacrylate (NBCA). Although a normal branch contributed to the collateral circulation proximal to the aneurysm, selective catheterization distal to the bifurcation was technically difficult. Thus, NBCA was injected from the point where the microcatheter was introduced as distally as possible, including one normal branch (Fig. 3D). Postoperative angiography revealed complete occlusion of the aneurysm (Fig. 3E). To manage the acute hydrocephalus caused by the hemorrhage, we performed right VD on the same day. Digital subtraction angiograms. Left vertebral angiography showed a 6-mm aneurysm in the distal portion of the left LPChA. A and B:Frontal (A) and lateral (B) view digital subtraction angiograms. C: Frontal view superselective angiogram. D: Embolization with 33% NBCA. E:Postembolization angiogram confirming complete obliteration of the aneurysm. The arrowheads indicate a normal branch arising from the proximal portion of the aneurysm. After embolization, the patient developed mild right hemiparesis. MRI performed 14 days after embolization revealed an infarction in the left corona radiata (Fig. 4A). Unfortunately, it gradually deteriorated during manual muscle testing from grade 4 to grade 2. A: Diffusion-weighted image obtained on day 24 demonstrating an infarction in the left corona radiata (arrowhead). B: Intraoperative findings on day 27 of endoscopic hematoma evacuation via the left posterior horn of the lateral ventricle. The embolized LPChA is identified (arrowheads). On day 27, endoscopic evacuation of the residual intraventricular hematoma and left VD were performed. After aspiration and removal of the choroid plexus hematoma, an embolized LPChA aneurysm was identified in the left lateral ventricle (Fig. 4B). Subsequently, we performed ventriculoperitoneal shunt placement and extracranial-intracranial bypass surgery. No further rebleeding occurred, and her Glasgow Coma Scale score improved to 10 (eyes 4, verbal 1, motor 5). She was transferred to a rehabilitation hospital with a modified Rankin Scale (mRS) score of 5. Informed Consent The necessary informed consent was obtained in this study. Discussion Observations Cases of rupture of a de novo aneurysm along a collateral vessel during the long-term observation of MMD, as in this case, are extremely rare. In this patient, periventricular aneurysm dilation was detected, and 1 month later, IVH occurred, followed by recurrent bleeding episodes. MMD causes hemorrhagic stroke, particularly in adults. The underlying mechanisms are thought to involve the development of fragile collateral vessels, formation of saccular aneurysms, and hemodynamic stress.3 Histopathological studies have shown that moyamoya vessels (dilated perforating arteries) exhibit various degenerative changes, including thinning of the media, duplication or disruption of the internal elastic lamina, and formation of microaneurysms, which may contribute to hemorrhage.3–5 However, the exact pathological mechanisms underlying the hemorrhagic complications of MMD remain unclear. Kawaguchi et al.6 reported that 22% of aneurysms associated with MMD are located along collateral pathways, such as the anterior or posterior choroidal arteries. Small aneurysms along collateral vessels are often difficult to detect before rupture, and few reports exist on the interval between aneurysm formation and rupture. Feng et al.7 reported that 70% of the MMD-associated aneurysm reruptures occurred within 35 days of the initial event. In that series, the earliest rerupture occurred 1 day after the initial hemorrhage, and 63.6% of the rerupture cases had poor outcomes (Glasgow Outcome Scale score 1–3 or mRS score 4–6). Because peripheral aneurysms are located deep within the brain, surgical intervention is technically challenging, and endovascular treatment such as coil embolization or parent artery occlusion is often selected as the definitive treatment. According to Tsuchiya et al.,8 the peripheral aneurysm location is significantly associated with treatment failure (defined as failure to achieve the intended therapeutic goal despite attempted endovascular treatment). Treatment failure occurred in 23 cases (12%), 21 of which were due to difficulty accessing the aneurysm. To date, no study has systematically characterized the complication profile of endovascular interventions for ruptured aneurysms arising from lateral choroidal arteries. A PubMed search performed on January 18, 2026, using the terms “lateral posterior choroidal artery aneurysm” and “case reports,” targeting reports of ruptured LPChA aneurysms treated with transarterial embolization, identified 4 publications9–12 encompassing 10 cases (Table 1). All 10 aneurysms were treated with NBCA embolization after rupture. Of these, 4 aneurysms (cases 1–4)9–11 were first identified at the time of rupture, and for 6 aneurysms (cases 5–10),12 the presence or absence of prior detection was not documented. Although 1 case (case 10)12 resulted in treatment failure attributable to the inability to access the aneurysm, no postprocedural complications were documented in the remaining 9 cases. Moreover, 8 patients (cases 2–9)10–12 were reported to have achieved complete recovery at discharge. Several technical factors have been cited as contributing to the low complication rates observed with embolization procedures: guiding the microcatheter into the aneurysm,9 using a high concentration (50%) of NBCA,9 utilizing a small and flexible flow-directable microcatheter,11 and achieving well-controlled injection techniques for liquid adhesive.9,11,12 TABLE 1.Cases of ruptured LPChA aneurysm treated with transarterial embolizationCase No.Age (yrs)/SexBasic DiseasesSize (mm)Timing of Treatment*Complications†Condition at Discharge180/MLt ICO, HTN, HL, MI3.3NANonemRS score 4254/MHTN, MI6Day 1NoneFully recovered352/FMMD3Day 7NoneFully recovered430/FNA3Day 12NoneFully recovered523/MMMDNANANoneFully recovered634/FMMDNANANoneFully recovered726/FMMDNANANoneFully recovered846/MMMDNANANoneFully recovered945/FMMDNANANoneFully recovered1041/MMMDNANAFailed (access)Retained neurological deficitPresent case54/FMMD6Day 10Infarction in the corona radiatamRS score 5HL = hyperlipidemia; HTN = hypertension; ICO = internal carotid artery occlusion; MI = myocardial infarction; NA = not available.* Day 0: day of rupture.† New neurological deficit/ischemic lesion on follow-up MRI. Cases of ruptured LPChA aneurysm treated with transarterial embolization HL = hyperlipidemia; HTN = hypertension; ICO = internal carotid artery occlusion; MI = myocardial infarction; NA = not available. * Day 0: day of rupture. † New neurological deficit/ischemic lesion on follow-up MRI. Revascularization surgery is known as a preventive treatment for intracranial hemorrhage in patients with MMD complicated by aneurysms.13 Several mechanisms have been proposed: disappearance of aneurysms due to increased intracranial blood flow and14 reduction of the hemodynamic burden on the posterior circulation by augmenting anterior circulation flow15 and consequently decreasing the risk of aneurysm growth or rupture.16 Although the disappearance of peripheral aneurysms was confirmed in 81.5% of the cases after revascularization, the mean time from diagnosis to disappearance was 7 months,7 indicating that the possibility of rerupture before aneurysm obliteration cannot be excluded. In some cases, observation may be chosen in anticipation of spontaneous regression of peripheral aneurysms; however, the likelihood of improvement is limited compared to that with active intervention. According to previous reports, 66.7% of peripheral aneurysms regressed spontaneously during follow-up; however, the time to disappearance ranged from 3 weeks to 1 year (mean 6.1 months).7 Another report8 showed that the risk of rerupture was significantly higher in ruptured aneurysms managed conservatively than in those treated definitively. Lessons Rerupture of peripheral aneurysms associated with MMD leads to a poor prognosis; therefore, early surgical intervention should be considered. In cases in which both surgical and endovascular treatments are technically challenging, elective revascularization aimed at promoting spontaneous aneurysm resolution may be an option, although this process can take several months. However, if the aneurysm ruptures repeatedly, embolization of the peripheral aneurysm should be considered, even though embolization may lead to clinical deterioration by reducing collateral circulation. Furthermore, similar cases are needed to establish optimal treatment strategies for aneurysms associated with MMD and to evaluate the risk of rebleeding and the appropriate timing of intervention. Acknowledgments We thank the individuals who contributed to article preparation but did not fulfill the criteria for authorship. Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. Author Contributions Conception and design: Hashizume, Enomoto, Izumo. Acquisition of data: Hashizume, Yasuda, Egashira, Enomoto. Analysis and interpretation of data: Hashizume, Egashira, Enomoto. Drafting the article: Hashizume, Yasuda, Kumagai. Critically revising the article: Yasuda, Egashira, Enomoto, Izumo. Reviewed submitted version of manuscript: Yasuda, Matsubara, Egashira, Enomoto, Izumo. Approved the final version of the manuscript on behalf of all authors: Hashizume. Administrative/technical/material support: Egashira. Study supervision: Enomoto, Izumo. Correspondence Rie Hashizume: Gifu University Graduate School of Medicine, Gifu, Japan. rie_1058@yahoo.co.jp. References